Claritine

Medicinal product

(Invented) name

Claritine

Active substance (s)

Loratadinas

Strength

10 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis/Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

R06AX13, Loratadine

Marketing authorisation holder

UAB Bayer, Lietuva

Date of authorisation

1997-04-09

Date of renewal

2009-09-16

Documents

1686_1_2_Claritine_tab_RPP_ 190114.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Loratadinas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
6794	11835	1011835	lizdinė plokštelė	N10		Nereceptinis	LT/1/97/1686/001	Tiekiama	-	-	No	-	-	Download
6795	2124	1002124	lizdinė plokštelė	N30		Receptinis	LT/1/97/1686/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2009-09-16	Perregistruotas
1997-04-09	Registruotas